Clinical Evaluation of Platelet Rich Fibrin Versus Subepithelial Connective Tissue Graft for Soft Tissue Augmentation
- Conditions
- Patients With at Least Single Missing Anterior ToothThin Gingival Biotype
- Interventions
- Procedure: sub epithelial connective tissue graftProcedure: Platelet Rich Fibrin
- Registration Number
- NCT03219944
- Lead Sponsor
- Cairo University
- Brief Summary
Soft tissue biotype is a critical factor for success of implant in the esthetic zone . Different soft tissue augmentation techniques have been employed to increase soft tissue thickness such as: autogenous grafts, allografts, xenografts and living cellular construct (LCC). Studies showed that, allografts and xenografts were inferior when compared with autogenous graft . However, few studies were conducted to evaluate the efficacy of soft tissue augmentation with platelet rich fibrin in order to overcome the patient morbidity with SCTG.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 16
- Patients with missing maxillary anterior toot teeth.
- Thin gingival biotype.
- Adequate inter-arch space for placement of the implant prosthetic part.
- Good oral hygiene where gingival index is (0, 1) (Loe and Silness 1963).
- Patient with medical condition that is contraindicated with the surgical procedure
- Patients receiving treatment that affect the healing ability.
- Patients with local pathological defects related to the area of interest.
- Smokers or pregnant women.
- Patients with parafunctional habits that may jeopardize the implant longevity and affect the results of the study.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description sub epithelial connective tissue graft sub epithelial connective tissue graft The connective tissue graft will be harvested from the palate. Then the SCTG will be placed over the recipient site extending palataly and sutured. Platelet Rich Fibrin for soft tissue augmentation Platelet Rich Fibrin blood will be drawn from the patient vein for PRF. The blood sample will be centrifuged for 10-12 min. PRF membrane is obtained
- Primary Outcome Measures
Name Time Method Crestal bone resorption 6 months measured mesially and distally using periapical xray in mm
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Maymohamedkamal
🇪🇬Cairo, Elmaniel, Egypt